Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027196 · ClinicalTrials.gov registry record
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 9,999,999
- Enrollment target
NCT00027196 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 9,999,999 participants.
The verdict
NCT00027196 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 9,999,999 participants
- Enrollment target
Study Summary
Genetically inherited heart diseases (familial cardiopathies) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Researchers are interested in learning more about the specific genetic abnormalities causing heart diseases. In addition, they would like to find out how these abnormal genes can contribute to the development of other medical problems. In order to do this, researchers plan to study patients and family members of patients diagnosed with genetically inherited heart disease. Those people participating in the study will undergo a variety of tests including blood tests, echocardiograms, and magnetic resonance imaging studies (MRI). These tests will be used to help researchers find the genetic problem causing the familial cardiopathy. Researchers hope that the information gathered from this study can be used to develop better medical care through early diagnosis, management, and treatment plans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,999,999 participants |
| Start Date | 1998-04 |
| Est. Completion | 2003-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027196
The ClinicalTrials.gov registry entry for NCT00027196 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,999,999 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00027196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027196 about?
NCT00027196 is a clinical study titled "Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease". Genetically inherited heart diseases (familial cardiopathies) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Researchers are interested in learning more about the s...
What is the current status of trial NCT00027196?
This trial is currently completed. The enrollment target is 9,999,999 participants. The study started on 1998-04. Estimated completion is 2003-04.
Who is sponsoring clinical trial NCT00027196?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.